Abstract
The effect of an acute physical stress on hormone secretions before and after a 10-day naltrexone treatment in untrained healthy and amenorrheic women was investigated. Plasma levels of pituitary (LH, FSH, prolactin, GH, ACTH, gB-endor-phin) and adrenal (Cortisol, androstenedione, testosterone) hormones were measured at rest and in response to 60 min of physical exercise. The test was done both before and after a 10-day naltrexone (50 mg/day) treatment. Graded levels of treadmill exercise (50, 70 and 90% of maximal oxygen uptake (V02) every 20 min) was used as physical stressor. While mean ± SE plasma LH levels in control women were higher than in amenorrheic patients and increased following the naltrexone treatment (p<0.01), no significant differences of basal plasma hormonal levels were observed between amenorrheic and eu-menorrheic women, both before and after naltrexone treatment. Physical exercise at 90% V02 induced a significant increase in plasma GH, ACTH, gB-endorphin, Cortisol, androstenedione and testosterone levels in controls before naltrexone treatment (plt;0.01). The mean increase in plasma androstenedione and testosterone levels in control women was significantly higher after naltrexone treatment (p<0.01). In amenorrheic patients before naltrexone, physical exercise induced an increase in plasma prolactin and GH levels, but not in plasma ACTH, gB-endorphin, Cortisol, testosterone and androstenedione. After naltrexone treatment, the exercise induced a significant plasma ACTH, gB-endorphin and Cortisol levels, while the increase of plasma prolactin levels was significantly higher than before treatment (p<0.01). In conclusion, the present data showing that physical conditioning in amenorrheic women does not induce the release of pituitary-adrenal cortex hormones and that this hormone is present following a naltrexone treatment suggest an involvement of opioidergic pathway in the neuroendocrine impairment of amenorrheic patients.
Similar content being viewed by others
References
Feicht C.B., Johnson T.S., Martin B.J., Sparkes K.E., Wagner W.W. Jr. Secondary amenorrhea in athletes. Lancet 2:1145, 1978.
Warren M.P. The effect of exercise on pubertal progression and reproductive function in girls. J. Clin. Endocrinol. Metab. 51:1150, 1980.
Loucks A.B., Horvath S.M. Exercise induced stress responses of amenorrheic and eumenorrheic runners. J. Clin. Endocrinol. Metab. 59:1109, 1984.
Rüssel J.B., Mitchell D., Musey P.I., Collins DC. The relationship of exercise to anovulatory cycles in female athletes: hormonal and physical characteristics. Obstet. Gynecol. 63:452, 1984.
Ronkainen H. Depressed follicle-stimulating hormone, luteinizing hormone and prolactin responses to the luteinizing hormone-releasing hormone, thyrotropin-releasing hormone and metoclopramide test in endurance runners in the hard-training season. Fertil. Steril. 44:755, 1985.
Ferin M., VanVugt D., Wardlaw S. The hypothalamic control of the menstrual cycle and the role of endogenous opiod peptides. Rec. Prog. Horm. Res. 40:441, 1984.
Sapolsky R.M., Krey LC. Stress-induced suppression of luteinizing hormone concentrations in wild baboons: role of opiates. J. Clin. Endocrinol. Metab. 66: 722, 1988.
Petraglia F., Vale W., Rivier C. Opiods act centrally to modulate stress-induced decrease in luteinizing hormone in the rat. Endocrinology 119:2445, 1986.
Gindoff P.R., Ferin M. Endogenous opiod peptides modulate the effects of corticotropin releasing factor on gonadotropin release in the primate. Endocrinology 121:837, 1987.
Taylor T., Dluhy R.G., Williams G.H. gB-endorphin suppresses adrenocorticotropin and Cortisol levels in normal human subjects. J. Clin. Endocrinol. Metab. 57:592, 1983.
Grossman A.B., Delitala G., Loy D.H., Besser G.M. An analogue of Met-enkephalin attenuates the Cortisol response to ovine corticotropin releasing factor. Clin. Endocrinol. (Oxf.) 25:421, 1986.
Honegger J., Navarra P., Tsagarakis S., Grossman A. Cytokine modulation of hypothalamic neuropeptides: interleukins regulate both growth and stress. In: Genazzani A.R., Nappi G., Petraglia F., Martignoni E. (Eds.), Stress and related disorders from adaptation to dysfunction. The Parthenon Publishing Group, Costerton Hall 1990, p. 31.
Grossman A., Clement-Jones V. Enkephalins and endorphins. Clin. Endocrinol. Metab. 12:31, 1983.
Laatikainen T. Plasma beta-endorphin and exercise in relation to menstrual disorders. In Genazzani A.R., Negri M. (Eds.), Opiod Peptides in Biological Fluids. The Parthenon Publishing Group, Costerton Hall, 1989, p.131.
Moretti C., Fabbri A., Gnessi L, Cappa M., Calzolari A., Fraiolo F., Grossman A.B., Besser G.M. Naloxone inhibits exercise-induced release of PRL and GH in athletes. Clin. Endocrinol. (Oxf.) 18:135, 1983.
Howlett T.A., Tomlin S., Hgahfoong L. Rees L.H., Bullen B.A., Skrinar G.S., Me Arthur J.W. Release of gB-endorphin and met-enkephalin during exercise in normal women: response to training. Br. Med. J. 288:1950, 1984.
Carr D.B., Bullen B.A., Skrinar G.S., Arnold M.A., Rosenblatt M., Beitins I.Z., Martin J.B., McArthur J.W. Physical conditioning facilitates the exercise-induced secretion of gB-endorphin and gB-lipotropin in women. N. Engl. J. Med. 305:560, 1981.
Petraglia F., Bacchi Modena A., Comitini G., Scazzina D., Facchinetti F., Fiaschetti D., Genazzani A.D., Barletta C, Scavo D., Genazzani A.R. Plasma beta-endorphin and beta-lipotropin levels increase in well trained athletes after competition and non competitive exercise. J. Endocrinol. Invest. 13:19, 1990.
Petraglia F., Barletta C, Facchinetti F., Spinazzola F., Monzani A., Scavo D., Genazzani A.R. Response of circulating adrenocorticotropin, beta-endorphin, beta-lipotropin and Cortisol to athletic competition. Acta Endocrinol. (Copenh.) 118:332, 1988.
Farrell P.A., Ward K.G., Maksud M.G., Morgan W.P. Increases in plasma gB-endorphin/gB-lipotropin im-munoreactivity after treadmill running in humans. Endogenous opiates and exercise. J. Appl. Physiol. 52:1245, 1982.
Gambert S.R., Garthwaite T.L., Pontzer C.H., Cook E.E., Tristani F.E., Duthie E.H., Martison D.R., Hagen T.C., McCarty D.J. Running elevates plasma gB-endorphin immunoreac-tivity and ACTH in untrained human subjects. Proc. Soc. Exp. Biol. Med. 168:1, 1981.
Rahkila P., Hakala E., Alen M., Salminen K., Laatikainen T. gB-endorphin and corticotropin release is dependent on a threshold intensity of running exercise in male endurance athletes. Life Sci. 43:551, 1988.
Brooks S., Burrin J., Cheetham M.F., Hall G.M., Yeo T., Williams C. The responses of the catecholamines and gB-endor-phin to brief maximal exercise in man. Eur. J. Appl. Physiol. 57: 230, 1988.
Berga S.L., Mortola J.F., Girton L, Suh B., Laughlin G., Pham P., Yen S.S.C. Neuroendocrine aberrations in women with functional hypothalamic amenorrhea. J. Clin. Endocrinol. Metab. 63:301, 1989.
Biller B.M.K., Federoff HJ., Koening J.I., Klibanski A. Abnormal Cortisol responses to corticotropin-releas-ing hormone in women with hypothalamic amenorrhea. J. Clin. Endocrinol. Metab. 70:311, 1990.
Luger A., Deuster P.A., Kyle S.B., Gallucci W.T., Montgomary L.C., Gold P.W., Loriaux L, Chrousos G.P. Acute hypothaiamic-pituitary-adrenal responses to the stress of treadmill exercise. N. Engl. J. Med. 376:1309, 1987.
Delitala G., Grossman A., Besser M. Differential effects of opiate peptides and alkaloids on anterior pituitary hormone secretion. Neuroendocrinology 37: 275, 1983.
Grossman A.B. Opioid peptides and reproductive function. Semin. Reprod. Endocrinol. 5:115, 1987.
Blankstein J., Reyes F.Y., Winter S.D., Faiman C. Endorphins and the regulation of human menstrual cycle. Clin. Endocrinol. (Oxf.) 14:287, 1981.
Quigley M.E., Sheenan K.L., Casper R.F., Yen S.S.C. Evidence for an increased dopaminergic and opiod activity in patients with hypothalamic amenorrhea. J. Clin. Endocrinol. Metab. 50:949, 1980.
Petraglia F., D’Ambrogio G., Comitini G., Facchinetti F., Volpe A., Genazzani A.R. Impairment of opiod control of luteinizing hormone secretion in menstrual disorders. Fertil. Steril. 43:535, 1985.
Grossman A.B., Gaillard R.C., Mc Carthy P., Rees LH., Besser G.M. Opiate modulation of the pituitary-adrenal axis: effects of stress and circadian rythm. Clin. Endocrinol. (Oxf.) 17:279, 1982.
Genazzani A.R., Pintor C., Facchinetti F., Carboni G., Pelosi U., Corda R. Adrenal and gonadal steroids in girls during sexual maturation. Clin. Endocrinol. (Oxf.) 8:15, 1978.
Genazzani A.R., Facchinetti F., Pintor C, Puggioni R., Parrini D., Petraglia F., Bagnoli F., Corda R. Proopiocortin-related peptide plasma levels throughout prepuberty and puberty. J. Clin. Endocrinol. Metab. 57:56, 1983.
Estivariz F.E., Iturizza F., McLean C., Hope J., Lowry P.J. Stimulation of adrenal mitogenesis by N-terminal proopiocortin peptides. Nature 297: 419, 1982.
Loucks A.B., Horvarth S.M. Exercise-induced stress responses of amenorrheic and eumenorrheic runners. J. Clin. Endocrinol. Metab. 59:1109, 1984.
Petraglia F., Vale W., Rivier C. Beta-endorphin and dynorphin participate in the stress-induced release of prolactin in the rat. Neuroendocrinology 45:338, 1987.
Wakabayashi I., Demura R., Miki N., Ohmura E., Miyoshi H., Shizume K. Failure of naloxone to influence plasma growth hormone, prolactin and Cortisol secretions induced by insulin hypoglycemia. J. Clin. Endocrinol. Metab. 50:597, 1980.
Cetel N.S., Quigley M.E., Yen S.S.C. Naloxone-induced prolactin secretion in women: evidence against a direct prolactin stimulatory effect of endogenous opioids. J. Clin. Endocrinol. Metab. 60:191, 1985.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Botticelli, G., Modena, A.B., Bresciani, D. et al. Effect of naltrexone treatment on the treadmill exercise-induced hormone release in amenorrheic women. J Endocrinol Invest 15, 839–847 (1992). https://doi.org/10.1007/BF03348817
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348817